Presented in collaboration with Be The Match BioTherapies®
Transfusion medicine, including blood bank, apheresis and the cellular therapy laboratory, is an integral part of a multitude and ever-growing number of clinical trials and investigations for medical innovation. Given the rapid evolution of therapies and interventions for which transfusion medicine services are required, it has become imperative that transfusion medicine professionals be well versed in the clinical trials process.
During pre-clinical and clinical development of new therapies, safety and clinical efficacy are studied. Understanding the general process of clinical trials as they progress through preparation and development, execution, and closing will help empower transfusion medicine professionals to actively participate in the process. Transfusion medicine services may be inundated with clinical trials for new therapies sponsored by industry so familiarity with different approaches to handling these trials from a transfusion medicine perspective is critical. In addition, innovation in transfusion medicine and development of clinical trials that are investigator- initiated is an integral part for the advancement of any field. Knowing how to start a clinical trial is important for academic investigators to advance their careers.
This session is designed to highlight important aspects of clinical trials development and participation that are relevant to the transfusion medicine community, with examples from blood bank, apheresis and cellular therapy laboratories.
Describe the general process for conducting clinical trials from initiation to close as it relates to transfusion medicine and cellular therapy
Discuss the operational considerations when preparing for clinical trials sponsored by external parties
Summarize the process for developing an investigator-initiated clinical trial